General description
INN
Enzalutamide
ATC codes
Medicine type
Chemical agent
EML status history
Application rejected in 2017
(TRS
1006)
for
Malignant neoplasms of prostate
Changed in 2021
(TRS
1035)
for
Malignant neoplasms of prostate
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Hormones and antihormones
- Oral > Solid: 40 mg
Indications